U.S. IPO Pipeline
| File Date |
Company (Ticker) Business Description |
Industry | Deal Size $(M) |
Underwriter |
|---|---|---|---|---|
10/09/26 |
Aspen Neuroscience (ASPE)
Phase 1/2a biotech developing stem cell therapies for Parkin... |
Health Care |
$100 |
Leerink Partners |
10/09/26 |
Bambusa Therapeutics (BBTX)
Phase 2 biotech developing bispecific antibodies for inflamm... |
Health Care |
$100 |
BofA |
10/09/26 |
OPay (OPAY)
Digital bank and fintech platform in Nigeria and other emerg... |
Financials |
$500 |
Citi |
See more U.S. IPO Pipeline companies on IPO Pro. |
See more U.S. IPO Pipeline companies on IPO Pro.
|
See more U.S. IPO Pipeline companies on IPO Pro. |
See more U.S. IPO Pipeline companies on IPO Pro. |
See more U.S. IPO Pipeline companies on IPO Pro. |
See more U.S. IPO Pipeline companies on IPO Pro. |
See more U.S. IPO Pipeline companies on IPO Pro.
|
See more U.S. IPO Pipeline companies on IPO Pro. |
See more U.S. IPO Pipeline companies on IPO Pro. |
See more U.S. IPO Pipeline companies on IPO Pro. |
See more U.S. IPO Pipeline companies on IPO Pro. |
See more U.S. IPO Pipeline companies on IPO Pro.
|
See more U.S. IPO Pipeline companies on IPO Pro. |
See more U.S. IPO Pipeline companies on IPO Pro. |
See more U.S. IPO Pipeline companies on IPO Pro. |
